Chemed Corporation (CHE)
$
451.9
-3.43 (-0.76%)
Key metrics
Financial statements
Free cash flow per share
25.4270
Market cap
6.6 Billion
Price to sales ratio
2.6215
Debt to equity
0.1215
Current ratio
1.8621
Income quality
1.4699
Average inventory
8.5 Million
ROE
0.2453
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The net total of other income and expenses is $32,972,000.00 reflecting non-core financial activities. The total costs and expenses for the company are $2,064,794,000.00 reflecting its overall spending. Additionally, the net income ratio is 0.12 reflecting the company's profitability margin. The company earned an interest income of $14,610,000.00 showcasing its financial investments. It operates in two segments: VITAS, focused on healthcare services, and Roto-Rooter, which provides plumbing and related services. The company's stock is identified with the symbol 'CHE' in the market, representing its presence within the competitive landscape. With its foundation dating back to 1970 and headquartered in Cincinnati, Ohio, Chemed Corporation continues to adapt and thrive in its service offerings. The stock is priced at $464.91 positioning it in the higher-end market, indicative of its perceived value among investors. However, the stock has a low average trading volume of 171,493.00 indicating lower market activity, which may suggest a niche interest. With a mid-range market capitalization of $6,584,951,230.00 the company is a steady performer in the financial landscape. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape and ensuring a diverse range of service offerings. Furthermore, it belongs to the Healthcare sector, driving innovation and growth within its fields of expertise while maintaining a solid reputation among its peers and stakeholders.
Is Chemed Corporation (CHE) a good investment?
Investing in Chemed Corporation (CHE) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bullish outlook. Always conduct your own research before investing.
What is Chemed Corporation (CHE)'s stock forecast?
Analysts predict Chemed Corporation stock to fluctuate between $408.42 (low) and $623.61 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Chemed Corporation's market capitalization?
As of 2025-08-29, Chemed Corporation's market cap is $6,584,951,230, based on 14,571,700 outstanding shares.
How does Chemed Corporation compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Chemed Corporation has a Lower Market-Cap, indicating a difference in performance.
Does Chemed Corporation pay dividends?
Chemed Corporation pays dividends. The current dividend yield is 0.49%, with a payout of $0.60 per share.
How can I buy Chemed Corporation (CHE) stock?
To buy Chemed Corporation (CHE) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CHE. Place an order (Market, Limit, etc.).
What is the best time to invest in Chemed Corporation?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Chemed Corporation stock ever split?
Chemed Corporation's last stock split was 2:1 on 2005-05-12.
How did Chemed Corporation perform in the last earnings report?
Revenue: $2,431,287,000 | EPS: $20.10 | Growth: 10.99%.
Where can I find Chemed Corporation's investor relations reports?
Visit https://www.chemed.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Chemed Corporation?
You can explore historical data from here
What is the all-time high and low for Chemed Corporation stock?
All-time high: $654.62 (2024-03-15) | All-time low: $403 (2021-10-12).
What are the key trends affecting Chemed Corporation stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
fool.com
Chemed (CHE -9.17%) -- home to hospice care provider Vitas Healthcare and Roto-Rooter -- saw its shares decline 9% as of 1 p.m. ET on Wednesday, according to data provided by S&P Global Market Intelligence.
zacks.com
Chemed (CHE) came out with quarterly earnings of $4.27 per share, missing the Zacks Consensus Estimate of $4.78 per share. This compares to earnings of $5.47 per share a year ago.
seekingalpha.com
Chemed Corporation's diversified revenue streams from VITAS Healthcare and Roto-Rooter provide a strong competitive advantage and resilience against sector-specific risks. Recent VITAS acquisition and expansion, along with robust Q1 results, highlight the company's growth potential and operational strength, especially in hospice care. My DCF analysis suggests Chemed is undervalued by over 50%, with a fair value estimate of $744 per share, supporting a buy rating.
businesswire.com
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange. Chemed also announced developments related to second quarter earnings and full year 2025 guidance. In prior public statements, management discussed the possibility that the VITAS subsidiary could have an aggregate Medicare Cap billing limitation (Med.
zacks.com
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
businesswire.com
CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cas.
zacks.com
Chemed delivers first-quarter top-line growth across two of its segments, VITAS and Roto-Rooter.
zacks.com
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
businesswire.com
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 35th Annual Healthcare Conference on Monday, March 17, 2025, at approximately 9:20 a.m. (ET). The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be acce.
See all news
